| 國立臺灣大學 |
2012 |
Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy
|
Liu, Chen-Hua; Liang, Cheng-Chao; Liu, Chun-Jen; Tseng, Tai-Chung; Lin, Chih-Lin; Yang, Sheng-Shun; Su, Tung-Hung; Hsu, Shih-Jer; Lin, Jou-Wei; Chen, Jun-Herng; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 蘇東弘; 徐士哲; 劉俊人; 陳培哲; 陳俊恒; 林昭維 |
| 臺大學術典藏 |
2018-09-10T09:23:42Z |
Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy
|
Chen, Jun-Herng; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; Chen, Jun-Herng; Lin, Jou-Wei; Lin, Jou-Wei; Hsu, Shih-Jer; Hsu, Shih-Jer; Su, Tung-Hung; Su, Tung-Hung; JIA-HORNG KAO; Lin, Chih-Lin; Yang, Sheng-Shun; Yang, Sheng-Shun; Liu, Chen-Hua;Liang, Cheng-Chao;Liu, Chun-Jen;Tseng, Tai-Chung;Lin, Chih-Lin;Yang, Sheng-Shun;Su, Tung-Hung;Hsu, Shih-Jer;Lin, Jou-Wei;Chen, Jun-Herng;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Liu, C.-H., Liang, C.-C., Liu, C.-J., Tseng, T.-C., Lin, C.-L., Yang, S.-S., Su, T.-H., Hsu, S.-J., Lin, J.-W., Chen, J.-H., Chen, P.-J., Chen, D.-S., Kao, J.-H.; 陳定信 ;劉振驊 ;高嘉宏 ;蘇東弘 ;徐士哲 ;劉俊人 ;陳培哲 ;陳俊恒 ;林昭維; 陳定信 ;劉振驊 ;高嘉宏 ;蘇東弘 ;徐士哲 ;劉俊人 ;陳培哲 ;陳俊恒 ;林昭維; Liu, Chen-Hua; CHUN-JEN LIU; Liu, Chen-Hua; Liang, Cheng-Chao; PEI-JER CHEN; Liang, Cheng-Chao; Liu, Chun-Jen; Liu, Chun-Jen; CHEN-HUA LIU; Tseng, Tai-Chung; DING-SHINN CHEN; Tseng, Tai-Chung; Lin, Chih-Lin; TUNG-HUNG SU |
| 臺大學術典藏 |
2021-05-24T07:20:46Z |
Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy
|
CHEN-HUA LIU; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Hsu S.-J.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:27Z |
Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Hsu S.-J.; Lin J.-W.; Chen J.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T06:12:00Z |
Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Hsu S.-J.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-03-09T01:47:46Z |
Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; TUNG-HUNG SU; Hsu S.-J.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 國立臺灣大學 |
2012 |
Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin
|
Liu, Chen-Hua; Liang, Cheng-Chao; Liu, Chun-Jen; Tseng, Tai-Chung; Lin, Chih-Lin; Yang, Sheng-Shun; Su, Tung-Hung; Lin, Jou-Wei; Chen, Jun-Herng; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 劉振驊; 高嘉宏; 蘇東弘; 劉俊人; 陳培哲; 陳俊恒; 林昭維 |
| 臺大學術典藏 |
2018-09-10T09:23:43Z |
Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin
|
Liu, Chen-Hua;Liang, Cheng-Chao;Liu, Chun-Jen;Tseng, Tai-Chung;Lin, Chih-Lin;Yang, Sheng-Shun;Su, Tung-Hung;Lin, Jou-Wei;Chen, Jun-Herng;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; Liu, C.-H., Liang, C.-C., Liu, C.-J., Tseng, T.-C., Lin, C.-L., Yang, S.-S., Su, T.-H., Lin, J.-W., Chen, J.-H., Chen, P.-J., Chen, D.-S., Kao, J.-H.; 陳定信 ;劉振驊 ;高嘉宏 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳俊恒 ;林昭維; 陳定信 ;劉振驊 ;高嘉宏 ;蘇東弘 ;劉俊人 ;陳培哲 ;陳俊恒 ;林昭維; Liu, Chen-Hua; Liu, Chen-Hua; CHUN-JEN LIU; Liang, Cheng-Chao; Liang, Cheng-Chao; PEI-JER CHEN; CHEN-HUA LIU; Liu, Chun-Jen; DING-SHINN CHEN; Tseng, Tai-Chung; TUNG-HUNG SU; Lin, Chih-Lin; Yang, Sheng-Shun; JIA-HORNG KAO; Su, Tung-Hung; Lin, Jou-Wei; Lin, Jou-Wei; Chen, Jun-Herng; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2021-05-24T07:20:46Z |
Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin
|
CHEN-HUA LIU; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-07-03T03:34:28Z |
Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Lin J.-W.; Chen J.-H.; PEI-JER CHEN; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2022-01-24T09:31:51Z |
Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin
|
Liu C.-H.; Liang C.-C.; CHUN-JEN LIU; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-03-09T01:47:46Z |
Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; TUNG-HUNG SU; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T06:12:00Z |
Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin
|
Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO |
| 國立臺灣大學 |
2010 |
Interleukin 4 and Stat6 Gene Polymorphisms Are Associated with Systemic Lupus Erythematosus in Chinese Patients
|
俞欣慧; 劉碧華; 陳為堅; 李志鴻; 王麗潔; 楊曜旭; 江伯倫; YU, HSIN-HUI; LIU, PI-HUA; CHEN, WEI-JANE; LEE, JYH-HONG; WANG, LI-CHIEH; YANG, YAO-HSU; CHIANG, BOR-LUEN |
| 臺大學術典藏 |
2020-12-08T08:20:26Z |
Interleukin 4 and STAT6 gene polymorphisms are associated with systemic lupus erythematosus in Chinese patients
|
Yu H.-H.;Liu P.-H.;Lin Y.-C.;Chen W.J.;Jyh-Hong Lee;Wang L.-C.;Yang Y.-H.;Chiang B.-L.; Yu H.-H.; Liu P.-H.; Lin Y.-C.; Chen W.J.; JYH-HONG LEE; Wang L.-C.; Yang Y.-H.; Chiang B.-L. |
| 臺大學術典藏 |
2020-12-21T07:40:27Z |
Interleukin 4 and STAT6 gene polymorphisms are associated with systemic lupus erythematosus in Chinese patients
|
Yu H.-H.;Liu P.-H.;Lin Y.-C.;Chen W.J.;Lee J.-H.;Li-Chieh Wang;Yang Y.-H.;Chiang B.-L.; Yu H.-H.; Liu P.-H.; Lin Y.-C.; Chen W.J.; Lee J.-H.; LI-CHIEH WANG; Yang Y.-H.; Chiang B.-L. |
| 臺大學術典藏 |
2020-12-17T02:28:42Z |
Interleukin 4 and STAT6 gene polymorphisms are associated with systemic lupus erythematosus in Chinese patients
|
Yang Y.-H.; Chiang B.-L.; Wang L.-C.; Hsin-Hui Yu;Liu P.-H.;Lin Y.-C.;Chen W.J.;Lee J.-H.;Wang L.-C.;Yang Y.-H.;Chiang B.-L.; HSIN-HUI YU; Liu P.-H.; Lin Y.-C.; Chen W.J.; Lee J.-H. |
| 臺大學術典藏 |
2021-01-06T08:23:42Z |
Interleukin 4 and STAT6 gene polymorphisms are associated with systemic lupus erythematosus in Chinese patients
|
Yu H.-H.;Liu P.-H.;Lin Y.-C.;Chen W.J.;Lee J.-H.;Wang L.-C.;Yao-Hsu Yang;Chiang B.-L.; Yu H.-H.; Liu P.-H.; Lin Y.-C.; Chen W.J.; Lee J.-H.; Wang L.-C.; YAO-HSU YANG; Chiang B.-L. |
| 臺大學術典藏 |
2021-07-02T03:41:57Z |
Interleukin 4 and STAT6 gene polymorphisms are associated with systemic lupus erythematosus in Chinese patients
|
Yu H.-H.; Liu P.-H.; Lin Y.-C.; Chen W.J.; Lee J.-H.; Wang L.-C.; Yang Y.-H.; BOR-LUEN CHIANG |
| 臺大學術典藏 |
2022-05-05T05:16:09Z |
Interleukin 4 and STAT6 gene polymorphisms are associated with systemic lupus erythematosus in Chinese patients
|
Yu H.-H.; Liu P.-H.; Lin Y.-C.; WEI J. CHEN; Lee J.-H.; Wang L.-C.; Yang Y.-H.; Chiang B.-L. |
| 亞洲大學 |
2005 |
Interleukin 4 Interleukin 6 and Interleukin 10 Polymorphisms in hildren with Acute and Chronic Immune Thrombocytopenic Purpura
|
Ching-Tien Peng |
| 亞洲大學 |
2005-03 |
Interleukin 4, interleukin 6 and interleukin 10 polymorphisms in children with acute and chronic immune thrombocytopenic purpura
|
Kang-His Wu;Ching-Tien Peng;Tsai-Chung Li;Lei Wan;Chang-Hai Tsai;Shou-Jen Lan;Ming-Cheng Chang;Fuu-Jen Tsai |
| 亞洲大學 |
2005 |
Interleukin 4, interleukin 6 and interleukin 10 polymorphisms in children with acute and chronic immune thrombocytopenic purpura
|
藍守仁 |
| 中國醫藥大學 |
2005-03 |
Interleukin 4, interleukin 6 and interleukin 10 polymorphisms in children with acute and chronic immune thrombocytopenic purpura
|
巫康熙(Kang-His Wu); 彭慶添(Ching-Tien Peng); 李采娟(Tsai-Chung Li); 萬磊(Lei Wan); 蔡長海(Chang-Hai Tsai); 藍守仁(Shou-Jen Lan); 張明正(Ming-Cheng Chang); 蔡輔仁(Fuu-Jen Tsai)* |
| 中國醫藥大學 |
2005 |
Interleukin 4, interleukin 6 and interleukin 10 polymorphisms in children with acute and chronic immune thrombocytopenic purpura
|
Wu, KH; Peng, CT; Li, TC; Wan, L; Tsai, CH; Lan, SJ; Chang, MC; Tsai, FJ |
| 中國醫藥大學 |
2005-11 |
Interleukin 4, interleukin 6 and interleukin 10 polymorphisms in children with acute and chronic immune thrombocytopenic purpura
|
巫康熙(Kang-Hsi Wu); 彭慶添(Ching-Tien Peng); 李彩娟(Tsai-Chung LI); 萬磊(Lei Wan); 蔡輔仁(Fuu-Jen Tsai) |
| 國立臺灣大學 |
2015 |
Interleukin 6 confers poor prognosis of hepatocellular carcinoma through cancer stemness properties
|
Chang, Te-Sheng; Wu, Yu-Chih; Chi, Ching-Chi; Tung, Shui-Yi; Ling, Thai-Yen; Huang, Yen-Hua; 林泰元 |
| 臺大學術典藏 |
2021-01-27T01:38:39Z |
Interleukin 8 modulates interleukin-1β, interleukin-6 and tumor necrosis factor-α release from normal human mononuclear cells
|
CHIA-LI YU; Sun K.-H.; Shei S.-C.; Tsai C.-Y.; Tsai S.-T.; Wang J.-C.; Liao T.-S.; Lin W.-M.; Chen H.-L.; Yu H.-S.; Han S.-H. |
| 國立成功大學 |
1998 |
Interleukin Binding Factor在調控人類免疫不全病毒基因表現所扮演的角色
|
黎慶 |
| 亞洲大學 |
2008-02 |
Interleukin gene polymorphisms in age-related macular degeneration
|
Yi-Yu Tsai;Jane-Ming Lin;Lei Wan;Hui-Ju Lin;Tsai-Chung Li;Chang-Hai Tsai;Fuu-Jen Tsai |
| 亞洲大學 |
2008-02 |
Interleukin gene polymorphisms in age-related macular degeneration
|
Tsai, YY (Tsai, Yi-Yu); Lin, JM (Lin, Jane-Ming); Wan, L (Wan, Lei); Lin, HJ (Lin, Hui-Ju); Tsai, YS (Tsai, Yushin); Lee, CC (Lee, Cheng-Chun); Tsai, CH (Tsai, Chang-Hai); Tsai, FJ (Tsai, Fuu-Jen); Tseng, SH (Tseng, Sung-Huei) |
| 國立成功大學 |
2008-02 |
Interleukin gene polymorphisms in age-related macular degeneration
|
Tsai, Yi-Yu; Lin, Jane-Ming; Wan, Lei; Lin, Hui-Ju; Tsai, Yushin; Lee, Cheng-Chun; Tsai, Chang-Hai; Tsai, Fuu-Jen; Tseng, Sung-Huei |
| 中國醫藥大學 |
2008-02 |
Interleukin gene polymorphisms in age-related macular degeneration.
|
蔡宜佑(Yi-Yu Tsai); 林正明(Jane-Ming Lin); 萬磊(Lei Wan); 林慧茹(Hui-Ju Lin); 蔡育勳; 李采娟(Tsai-Chung Li); 蔡長海(Chang-Hai Tsai); 蔡輔仁(Fuu-Jen Tsai)* |
| 國立中正大學 |
2012 |
Interleukin- 6透過STAT3機制以啟動頭頸癌鱗狀上皮細胞株Haptoglobin 蛋白的表現
|
李思錦; Szu Chin, Li |
| 中國醫藥大學 |
2005 |
Interleukin-1 (IL-1) mediates parkinsonism-induced sleep alterations
|
Chang, F; Yi, P; Tsai, C; Chen, Y |
| 臺大學術典藏 |
2005 |
Interleukin-1 (IL-1) mediates Parkinsonism-induced sleep alterations.
|
Chang, Fang-Chia;Yi, Pei-Lu;Tsai, Chon-Haw;Chen, Ya-Ju; Chang, Fang-Chia; Yi, Pei-Lu; Tsai, Chon-Haw; Chen, Ya-Ju |
| 國立臺灣大學 |
2005 |
Interleukin-1 (IL-1) mediates Parkinsonism-induced sleep alterations.
|
Chang, Fang-Chia; Yi, Pei-Lu; Tsai, Chon-Haw; Chen, Ya-Ju |
| 中國醫藥大學 |
2001 |
Interleukin-1 and interleukin-1 receptor antagonist gene polymorphisms in rheumatoid arthritis.
|
黃春明(Chung-Ming Huang); 蔡輔仁(Tsai,Fuu-Jen)*; 鄔哲源(Wu,Jer-Yuarn); 吳梅珍(Mei-Chen Wu) |
| 臺大學術典藏 |
1997 |
Interleukin-1 and tumor necrosis factor alter plasma concentration and interorgan fluxes of taurine in dogs
|
Hashiguchi Y.; Fukushima R.; Saito H.; Naka S.; Inaba T.; MING-TSAN LIN; Muto T. |
| 中國醫藥大學 |
2003 |
Interleukin-1 beta and interleukin-1 receptor antagonist gene polymorphism in postmenopausal women: correlation to bone mineral density and susceptibility to osteoporosis
|
Chen, HY; Chen, WC; Wu, MC; Tsai, FJ; Lin, CC |
| 中國醫藥大學 |
2001 |
Interleukin-1 beta and interleukin-1 receptor antagonist gene polymorphisms in rheumatoid arthritis
|
Huang, CM; Tsai, FJ; Wu, JY; Wu, MC |
| 中國醫藥大學 |
2001 |
Interleukin-1 beta and interleukin-1 receptor antagonist gene polymorphisms in rheumatoid arthritis
|
Huang, CM; Tsai, FJ; Wu, JY; Wu, MC |
| 中國醫藥大學 |
2001 |
Interleukin-1 beta gene and receptor antagonist gene polymorphisms in patients with calcium oxalate stones
|
Chen, WC; Wu, HC; Chen, HY; Wu, MC; Hsu, CD; Tsai, FJ |
| 中國醫藥大學 |
2005-03 |
Interleukin-1 beta gene but not interleukin-1 receptor antagonist gene is associated with graves’ disease
|
陳榮興(R-H Chen); 張淳堆(C-T Chang); 陳汶吉(W-C Chen); 蔡輔仁(F-J Tsai) |
| 中國醫藥大學 |
2005 |
Interleukin-1 beta gene polymorphisms in Taiwanese patients with gout
|
Chen, ML; Huang, CM; Tsai, CH; Tsai, FJ |
| 國立臺灣大學 |
2009 |
Interleukin-1 Beta Is Increased in the Cerebrospinal Fluid of Patients with Small Infarcts
|
孫瑜; 呂建榮; 林正懷; 溫力立; SUN, YU; LU, CHIEN-JUNG; LIN, C-H; WEN, LI-LI |
| 國家衛生研究院 |
2015-11 |
Interleukin-1 beta transactivates epidermal growth factor receptor via the CXCL1-CXCR2 axis in oral cancer
|
Lee, CH;Syu, SH;Liu, KJ;Chu, PY;Yang, WC;Lin, P;Shieh, WY |
| 國立臺灣大學 |
2003 |
Interleukin-1 Beta, Clinical Parameters and Matched Cellular- Histopahtologic Changes of Biopsied Gingival Tissue from Periodontitis Patients
|
侯連團; 劉謙美; 劉步遠; 林世榮; 廖嘉士; HOU, LEIN-TUAN; LIU, CHEING-MEEI; LIU, BU-YUAN; LIN, SHIH-JUNG; LIAO, CHIA-SHIH |
| 中山醫學大學 |
2021 |
Interleukin-1 beta-induced matrix metalloproteinase-3 via ERK1/2 pathway to promote mesenchymal stem cell migration
|
Chang, CH; Lin, YL; Tyan, YS; Chiu, YH; Liang, YH; Chen, CP; Wu, JC; Wang, HS |
| 中國醫藥大學 |
1999 |
Interleukin-1 beta-induced release of matrix proteins into culture media causes inhibition of mineralization of nodules formed by periodontal ligament cells in vitro
|
Chien, HH; Lin, WL; Cho, MI |
